Illustration: Radina Dobrinova for Endpoints News

Rav­gen con­tin­ues its le­gal re­venge saga with a $57M ver­dict over Nat­era

Rav­gen, a com­pa­ny that was a blip in pre­na­tal screen­ing not long ago, has con­tin­ued its streak of le­gal vic­to­ries against much larg­er com­pa­nies thanks to an­oth­er mul­ti­mil­lion-dol­lar ver­dict.

A ju­ry in the US Dis­trict Court for the West­ern Dis­trict of Texas de­cid­ed that Nat­era must pay Rav­gen $57 mil­lion for in­fring­ing on a Rav­gen patent, the com­pa­nies said on Tues­day.

In 2020, Rav­gen em­barked on a sprawl­ing le­gal cam­paign and ac­cused some of the biggest names in the test­ing busi­ness of copy­ing its non­in­va­sive pre­na­tal test. The small com­pa­ny was award­ed $375.5 mil­lion from Lab­o­ra­to­ry Cor­po­ra­tion of Amer­i­ca, bet­ter known as Lab­corp, af­ter a ju­ry ver­dict and a judge’s or­der for puni­tive dam­ages. Lat­er, oth­er lab gi­ants — Quest Di­ag­nos­tics, PerkinElmer and Il­lu­mi­na — set­tled for undis­closed sums.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Life Sciences Senior Associate

General Catalyst

San Francisco, CA, USA